Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Spironolactone in Acute Heart Failure
NCT04618601Phase 4Unknown
- Sponsor
- Laiko General Hospital
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in heart failure (HF), sponsored by Laiko General Hospital. Status: unknown.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04618601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618601.